| Omosede O Ighile, MD | |
|
593 Eddy St, Providence, RI 02903 | |
| (401) 444-3985 | |
| (401) 444-3986 |
| Full Name | Omosede O Ighile |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891133146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD15383 (Rhode Island) | Secondary |
| 207R00000X | Internal Medicine | MD15383 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
News Archive
Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire iForce.
The American Society of Anesthesiologists- (ASA-) today announced the launch of its ASA Perioperative Surgical Home Learning Collaborative, a national initiative designed to improve the patient experience before, during and after surgery. More than 40 leading health care organizations from across the country will participate in the collaborative, which will convene for the first time at the ASA's PSH Learning Collaborative Launch, July 25-26, in Schaumburg, Ill.
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has attained a key success milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Shire Pharmaceuticals. The milestone, which triggered an undisclosed payment from Shire, was the first demonstration of in vivo proof of concept for one of the antibody discovery programs undertaken in the collaboration.
Today's early morning highlights include articles on new options for open season, concerns among retirees about the provisions of the federal health law and the latest campaign arguments over that new overhaul.
› Verified 5 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire iForce.
The American Society of Anesthesiologists- (ASA-) today announced the launch of its ASA Perioperative Surgical Home Learning Collaborative, a national initiative designed to improve the patient experience before, during and after surgery. More than 40 leading health care organizations from across the country will participate in the collaborative, which will convene for the first time at the ASA's PSH Learning Collaborative Launch, July 25-26, in Schaumburg, Ill.
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has attained a key success milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Shire Pharmaceuticals. The milestone, which triggered an undisclosed payment from Shire, was the first demonstration of in vivo proof of concept for one of the antibody discovery programs undertaken in the collaboration.
Today's early morning highlights include articles on new options for open season, concerns among retirees about the provisions of the federal health law and the latest campaign arguments over that new overhaul.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omosede O Ighile, MD 117 Ellenfield St Ste 101, Providence, RI 02905-4513 Ph: (401) 444-6779 | Omosede O Ighile, MD 593 Eddy St, Providence, RI 02903 Ph: (401) 444-3985 |
News Archive
Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire iForce.
The American Society of Anesthesiologists- (ASA-) today announced the launch of its ASA Perioperative Surgical Home Learning Collaborative, a national initiative designed to improve the patient experience before, during and after surgery. More than 40 leading health care organizations from across the country will participate in the collaborative, which will convene for the first time at the ASA's PSH Learning Collaborative Launch, July 25-26, in Schaumburg, Ill.
BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has attained a key success milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Shire Pharmaceuticals. The milestone, which triggered an undisclosed payment from Shire, was the first demonstration of in vivo proof of concept for one of the antibody discovery programs undertaken in the collaboration.
Today's early morning highlights include articles on new options for open season, concerns among retirees about the provisions of the federal health law and the latest campaign arguments over that new overhaul.
› Verified 5 days ago
Christopher Donald Palmer, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 Fax: 401-453-7597 | |
Martha Catherine Trimbur, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Chapman St Ste 300, Providence, RI 02905 Phone: 401-444-4741 Fax: 401-444-4445 | |
Karl Herman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Fain Bldg., Providence, RI 02906 Phone: 401-793-4489 Fax: 401-793-4047 | |
Muhammad Baig, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Fain Bldg, Providence, RI 02906 Phone: 401-793-4489 Fax: 401-793-4047 | |
Dr. Peter Sidhom, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 603-560-2276 | |
Dr. Kanhai Farrakhan, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-457-3336 Fax: 401-525-2349 | |
Gary M Katzman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Collyer Street, Suite 100, Providence, RI 02904 Phone: 401-793-7191 Fax: 401-793-7200 |